Skip to main content
SpringerLink
Log in

Spezifische Hyposensibilisierung bei Typ-I-Allergien

  • Chapter
Book cover Therapie der Hautkrankheiten

  • 227 Accesses

Zusammenfassung

Die spezifische Hyposensibilisierung entspricht einer Immuntherapie, bei der wiederholt und in steigenden Mengen ein relevantes Allergenextrakt bis zum Erreichen einer Erhaltungsdosis appliziert wird, um Symptomfreiheit bzw. Beschwerdelinderung zu erreichen. Sie ist die einzige Möglichkeit, Allergien gegen nicht vermeidbare Allergene möglichst kausal anzugehen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 378.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adorini L (1995) Tipping the Th1/Th2 balance: an approach to the immunotherapy of autoimmune and allergic diseases. In: Johansson SGO (ed) Progress in allergy and clinical immunology, vol 3. Hogrefe & Huber, Seattle Toronto Bern Göttingen, pp 290–295

    Google Scholar 

  • Ahnefeld FW, Barth J, Dick W et al. (1995) Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Dermatosen 43:281–289

    Google Scholar 

  • Balda BR, Wolf H, Baumgarten C et al. (1998) Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy 53:740–748

    Article  PubMed  CAS  Google Scholar 

  • Bertelsen A, Andersen JB, Christensen J, Ingemann L, Kristense T, Ostergaard PA (1989) Immunotherapy with dog and cat extracts in children. Allergy 44:330–335

    Article  PubMed  CAS  Google Scholar 

  • Bertoni M, Cosmi F, Bichi I, Di Berardino L. (1999) Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis. Ann Allergyy Asthma Immunol 82:47–51

    Article  CAS  Google Scholar 

  • Bjorksten B (1994) Local immuntherapy is not documented for clinical use. Allergy 49:299–301

    Article  PubMed  CAS  Google Scholar 

  • Bousquet J, Hejjaoui A, Michel FB (1990) Specific immunotherapy in asthma. J Allergy Clin Immunol 86:292–305

    Article  PubMed  CAS  Google Scholar 

  • Bousquet J, Lockey RF, Mailing HJ (1998) WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53 [Suppl 44]: 1–42

    Google Scholar 

  • Frank E (1994) Retrospektive Untersuchung über die Hypo-sensibilisierungsbehandlung von Milbenallergikern mit Novo-Helisen Depot. Allergologie 4:154–159

    Google Scholar 

  • Giovane AL, Vadare M, Passalacqua G et al. (1994) A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 24:53–59

    Article  PubMed  CAS  Google Scholar 

  • Haseiden BM, Kay AB (1998) Nasal immunhotherapy-not to be sneezed at. Clin Exp Allergy 28:392–394

    Article  Google Scholar 

  • Haugaard LR, Jacobsen L (1993) A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 91:709–722

    Article  PubMed  CAS  Google Scholar 

  • Horak F, Stubner P, Berger UE et al. (1998) Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study. J Investig Allergol Clin Immunol 8: 165–171

    PubMed  CAS  Google Scholar 

  • Hordijk GJ, Antvelink JB, Luwema RA et al. (1998) Sublingual immunotherapy with a standardized grass pollen extract; a double-blind placebo-controlled study. Allergol Immunopathol 26: 234–240

    CAS  Google Scholar 

  • Mailing HJ (1998) Immunotherapy as an effective tool in allergy treatment. Allergy 53:461–472

    Article  Google Scholar 

  • Mailing HJ, Weeke B (1993) Immunotherapy. Position Paper of the EAAIC. Allergy 48 [Suppl 14]: 7–35

    Google Scholar 

  • Mosbech H, Østerballe O (1988) Does the effect of immunotherapy last after termination of treatment? Allergy 43: 523–529

    Article  PubMed  CAS  Google Scholar 

  • Müller U, Mosbech H, Aberer W et al. (1995) Adrenaline for emergency kits. Allergy 50:783–787

    Article  PubMed  Google Scholar 

  • Pichler CE, Marquardsen A, Sparholt S et al. (1997) Specific immmunotherapy with Dermatophagoides pteronyssimus and D. farinae results in decreased bronchial hyperreactivity. Allergy 52: 274–283

    Article  PubMed  CAS  Google Scholar 

  • Sabbah A, Hassoun S, Le Sellin J et al. (1994) A double blind, placebo-controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 49:309–313

    Article  PubMed  CAS  Google Scholar 

  • Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR (1991) Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br Med J 302: 265–269

    Article  CAS  Google Scholar 

  • Wahn U, Schweter C, Lind P, Lowenstein H (1988) Prospective study on immunologic changes induced by two different Dermatophagoides pteronyssinus extracts prepared from whole mite culture and mite bodies. J Allergy Clin Immunol 82:360–370

    Article  PubMed  CAS  Google Scholar 

  • Ahnefeld FW, Barth J, Dick W et al. (1995) Akuttherapie anaphylaktoider Reaktionen. Ergebnisse einer interdisziplinären Konsensuskonferenz. Dermatosen 43: 281–289

    Google Scholar 

  • Björnsson E, Janson C, Plaschke P et al. (1995) Venom allergy in adult Swedes: a population study. Allergy 50: 800–805

    Article  PubMed  Google Scholar 

  • Bousquet J, Lockey RF, Mailing HJ (1998) WHO Position Paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy 53 [Suppl 44]: 1–42

    Google Scholar 

  • Brockow K, Kiehn M, Riethmuller C, Vieluf D, Berger J, Ring J (1997) Efficacy of antistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 100: 458–463

    Article  PubMed  CAS  Google Scholar 

  • Charpin D, Birnbaum J, Vervloet D (1994) Epidemiology of hymenoptera allergy. Clin Exp Allergy 24:1010–1015

    Article  PubMed  CAS  Google Scholar 

  • Goldberg A, Confino-Cohen R, Mekori YA (1994) Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients. Ann Allergy 75: 30–32

    Google Scholar 

  • Graft DF (1990) When to start, when to stop, and what to measure in venom immunotherapy: issues in allergy. Grand seminar; AAAI Annual Meeting 1990. J Allergy Clin Imunol 88:409–413

    Article  Google Scholar 

  • Graft DF, Schoenwetter WF (1994) Insect sting allergy: analysis of a cohort of patients who initiated venom immunotherapy from 1978 to 1986. Ann Allergy 73: 481–485

    PubMed  CAS  Google Scholar 

  • Haugaard L, Norregaard OFH, Dahl R (1991). In-hospital sting challenge in insect venom-allergic patients after stopping venom immunotherapy. J Allergy Clin Immunol 87: 699–702

    Article  PubMed  CAS  Google Scholar 

  • Jeep S, Kirchhof E, O’Connor A, Kunkel G (1994). Comparison of the Phadebas RAST with the Pharmacia CAP system for insect venom. Allergy 7:212–217

    Google Scholar 

  • Jeep S, Meysel U, Kunkel G (1994) IgE, IgG, IgG1 and IgG4 patterns in yellow jacket allergic patients during immunotherapy with a venom depot extract. Clin Exp Allergy 22: 97–302

    Google Scholar 

  • King TP, Hoffman D, Lowenstein H et al. (1995) Allergen nomenclature. J Allergy Clin Immunol 96:5–14

    Article  CAS  Google Scholar 

  • Lantner R, Reisman RE (1989) Clinical and immunologic features and subsequent course of patients with severe insect-sting anaphylaxis. J Allergy Clin Immunol 84: 900–906

    Article  PubMed  CAS  Google Scholar 

  • Linden PWG van der, Hack E, Struyvenberg A et al. (1994) Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurence and the severity of anaphylaxis. J Allergy Clin Immunol 94:151–159

    Article  PubMed  Google Scholar 

  • Mailing HJ (1994) Immunotherapy in Europe. Clin Exp Allergy 24:515–521

    Article  Google Scholar 

  • Mosbech H, Mailing HJ, Biering I et al. (1986) Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 41: 95–103

    Article  PubMed  CAS  Google Scholar 

  • Müller U (1988) Insektenstichallergie. Klinik, Diagnostik und Therapie. Fischer, Stuttgart New York

    Google Scholar 

  • Müller U, Berchtold E, Helbling A (1991) Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients. J Allergy Clin Immunol 87:702–709

    Article  PubMed  Google Scholar 

  • Müller U, Helbling A, Berchtold E (1992) Immunotherapy with honeybee venom and yellow jacket venom is different regaring efficacy and safety. J Allergy Clin Immunol 89:529–535

    Article  PubMed  Google Scholar 

  • Müller UR, Dudler T, Schneider T et al. (1995) Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar. J Allergy Clin Immunol 96:395–402

    Article  PubMed  Google Scholar 

  • Müller U, Mosbech H, Aberer W et al. (1995) Adrenaline for emergency kits. EAACI Position Paper. Allergy 50:783–787

    Article  PubMed  Google Scholar 

  • Przybilla B, Ring J, Grießhammer B et al. (1987) Schnell-hyposensibilisierung mit Hymenopterengiften. Verträglichkeit und Therapieerfolg. Dtsch Med Wochenschr 112: 416–424

    Article  PubMed  CAS  Google Scholar 

  • Przybilla B, Ring J, Rieger B (1994) Die Indikation zur Hymenopterengift-Hyposensibilisierung kann nicht anhand eines diagnostische Parameter bewertenden Punkteschemas gestellt werden. Allergologie 4:114–119

    Google Scholar 

  • Reisman RE (1993) Duration of venom immunotherapy: relationship to the severtity of symptoms of initial insect sting anaphylaxis. J Allergy Clin Immunol 92: 831–836

    Article  PubMed  CAS  Google Scholar 

  • Reunala T, Brummer-Korvenkontio H, Lappalainen P et al. (1990) Immunology and treatment of mosquito bites. Clin Exp Allergy 20:19–24

    Article  PubMed  Google Scholar 

  • Reunala R, Brummer-Korvenkontio H, Räsänen L et al. (1994) Passive transfer of cutaneous mosquito-bite hypersensitivity by IgE anti-saliva antibodies. J Allergy Clin Immunol 94: 902–906

    Article  PubMed  CAS  Google Scholar 

  • Rueff F, Przybilla B, Müller U, Mosbech H (1996) The sting challenge test in hymenopterea venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 51: 216–225

    PubMed  CAS  Google Scholar 

  • Treudler R, Tebbe B, Orfanos CE (1997) Standardisierte Schnellhyposensibilisierung mit einem gereinigten Hymenopterengift bei Wespengiftallergie. Prospektive Studie zu Toleranzentwicklung und Nebenwirkungsprofil. Hautarzt 48:734–739

    Article  PubMed  CAS  Google Scholar 

  • Valentine MD, Schuberth KC, Cobotka AK et al. (1990) The value of immunotherapy with venom in children with allergy to insect stings. N Engl J Med 323:1601–1603

    Article  PubMed  CAS  Google Scholar 

  • Wyss M, Scheitlin T, Stadler BM et al. (1993) Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy 48: 81–86

    Article  PubMed  CAS  Google Scholar 

  • Yu Y, Weck AL de, Stadler BM et al. (1995) Anti-IgE autoantibodies and bee-sting allergy. Allergy 50:119–125

    Article  PubMed  CAS  Google Scholar 

  • Durham SR (1995) New insights into the mechanisms of immunotherapy. Eur Arch Otorhinolarngol 252: 64–67

    Article  Google Scholar 

  • Furin MJ, Norman PS, Creticos PS et al. (1991) Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 88: 27–32

    Article  PubMed  CAS  Google Scholar 

  • McHugh SM, Deighton J, Stewart AG et al. (1995) Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy 25: 828–838

    Article  PubMed  CAS  Google Scholar 

  • Secrist H, Chelen CJ, Wen Y et al. (1993) Allergen immunotherapy decreases interleukin-4 produktion in CD4 T-cells from allergic individuals. J Exp Med 178: 2123–2130

    Article  PubMed  CAS  Google Scholar 

  • Till S, Walker S, Dickason R et al. (1997) Interleukin 5 production by allergen-stimulated T cells following grass pollen immunotherapy for seasonal allergic rhinitis. Clin Exp Immunol 110:114–121

    Article  PubMed  CAS  Google Scholar 

  • Varnay VA, Hamid QA, Gaga M et al. (1993) Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest 92:644–651

    Article  Google Scholar 

  • Weber RW (1997) Immunotherapy with allergens. JAMA 278:1881–1887

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin Freie Universität Berlin, Fabeckstr. 60-62, 14195, Berlin, Deutschland

    Prof. Dr. Prof. h. c. Constantin E. Orfanos

  2. Hautklinik und Poliklinik, Eberhard-Karls-Universität, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h. c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

U. Blume-Peytavi C. C. Geilen S. Goerdt H. Gollnick E. Haneke F.-M. Köhn B. Tebbe R. Treudler Ch. C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (2002). Spezifische Hyposensibilisierung bei Typ-I-Allergien. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56219-8_12

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62541-1

  • Online ISBN: 978-3-642-56219-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation